Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Immunology
Using RAG Knockouts to Study Immune Receptor Diversity
Cyagen Technical Content Team | August 05, 2025
--
--
--
Contents
01. Introduction to RAG1 and RAG2 02. 12/23 Rule on V(D)J recombination 03. Distinctions Between RAG1 and RAG2 04. Summary 03. References

The recombination-activating genes, RAG1 & RAG2, play an essential role in lymphoid cell V(D)J recombination, which affects the production of highly diverse antibodies and T cell receptors (TCRs) in B and T cells. We will review the background information, research insights, and applications of RAG1 & RAG2, hoping to provide helpful information for your scientific innovation.

Introduction to RAG1 and RAG2

We know that immunoglobulins (Ig) produced by B cells – integrated into both B cell surface receptors (BCR) and antibodies - and T cell surface receptors (TCR) on T cells are specific: an Ig or TCR protein can specifically recognize only one antigen. However, overall, these proteins have enormous diversity achieved by V(D)J recombination. V(D)J recombination is a somatic recombination mechanism during early T and B cell developmental maturation in vertebrates that generates diverse immunoglobulins and TCRs, which recognize different antigens by reassortment of variable (V), diversity (D), and joining (J) genes. Moreover, recombination activating genes (RAGs) RAG1 and RAG2 respectively encode the RAG-1 and RAG-2 recombinases. RAG1 and RAG2 are restrictively expressed in developing lymphocytes and are essential components of the adaptive immune system.

12/23 Rule on V(D)J recombination

The recombination signal sequence (RSS) is present on both ends of the V, D, and J regions in germline genes for Ig and TCR. Structurally, the RSS has a 7 bp sequence (heptamer) at one end and a 9 bp sequence (nonamer) at the other, with a 12 bp or 23 bp spacer sequence sandwiched between them. Therefore, the RSS can be divided into two types: 12-RSS with a 12 bp spacer, and 23-RSS with a 23 bp spacer (Figure 1a). The 12/23 rule means that during V(D)J recombination, 12-RSS can only be combined with 23-RSS to ensure the correct joining of gene fragments. As an example, in germline genes of Ig heavy chain (IgH), the VH and JH genes are flanked by 23-RSS, while the DH gene is flanked by 12-RSS, so the 12/23 rule prevents direct joining of VH and JH genes, ensuring that the DH gene is involved in rearrangements (Figure 1b). Furthermore, from a molecular level, 12-RSS and 23-RSS binding also enable the formation of a more stable synaptonemal complex (synapsis).

During V(D)J recombination, the RAG1/2 complex - with the assistance of high mobility group box 1 (HMGB1), which assists DNA binding - precisely introduces a single-strand nick at the junction of the heptamer and the coding-end of the RSS. The incision generates a free 3 '- OH group at the end of the coding sequence that subsequently attacks the phosphodiester bond in the antiparallel strand to form a hairpin structure as well as a blunt signal end. The signal ended remains bound to the RAG1/2 complex and constitutes a transient structure of a "post cleavage complex." Subsequently, both the coding and signal end undergo processing and ligation by the non-homologous end joining (NHEJ) pathway to form the coding joint and the circularized signal joint (Fig.1c).

Fig. 1. V(D)J rearrangements [1]

(a) RSS structure: 12-RSS and 23-RSS: 7 bp heptamer and 9 bp nonamer sandwiched with a 12 bp spacer or a 23 bp spacer, respectively.

(b) The distribution of RSS in human IgH, IGK, IGL, as well as TCR α, β, γ, and δ chain genes.

(c) V(D)J recombination mechanisms.

Distinctions Between RAG1 and RAG2

What are the functional differences between RAG1 and RAG2? Dr. Akamatsu's experiments show that in the presence of RSS and nonspecific DNA sequences, RAG-1 binding to RSS is only 3 to 5 times higher than that of nonspecific DNA sequences. Alternatively, for RAG-2, no binding to DNA was observed experimentally. However, when RAG-1 and RAG-2 are present, they can form a RAG1/2 complex with DNA, which is more stable and specific than the RAG1-DNA complex and has cleavage activity in V(D)J recombination. These results illustrate that RAG2 may function in V(D)J rearrangements to assist RAG1 recognition of DNA and that efficient binding versus recognition of the RSS requires the concomitant presence of both RAG-1 and RAG-2 [2].

Summary

Both RAG-1 and RAG-2 recombinases are critical for the development and maturation of T and B cells and the production of immunoglobulin. In V(D)J recombination, the RAG1/2 complex is involved in the recognition and splicing of RSS. Thus, in contrast to mice with PrkdcSCID gene mutation, Rag1, and Rag2 knockout (KO) mice lack functional T and B cells and immunoglobulins because of the disruption in their V(D)J rearrangement pathways and do not experience immune leakage ("leakiness"). The incidence of immune leakage varies among SCID mice of different genetic backgrounds. In general, SCID mice show high leakage rates on the C57BL/6J and BALB/c backgrounds, lower on a C3H background, while being extremely low on the NOD background. However, the molecular mechanisms that generate the immune leakage remain unclear currently.

Explore the frontiers of immunology research with our Rag1 and Rag2 KO mice – visit Cyagen's MouseAtlas Model Library today!

MouseAtlas Model
  • AAALAC-Accredited and OLAW Assured
  • No risk of failure: Our catalog features gene knockout mice that have been strictly analyzed to ensure 100% positive knockout
  • 100% pure B6 background eliminates the need for backcrossing – most repositories have mixed backgrounds
References

[1] Nishana, M., & Raghavan, S. C. (2012). Role of recombination activating genes in the generation of antigen receptor diversity and beyond. Immunology, 137(4), 271–281.

[2] Akamatsu Y, Oettinger MA. (1998). Distinct roles of RAG1 and RAG2 in binding the V(D)J recombination signal sequences. Mol Cell Biol, 18(8):4670-8.

Subscribe to Receive Updates & Promotions From Cyagen
Subscribe
* Your privacy matters to us. We never share it with third parties.
Explore More
From Challenge to Cure: A Breakthrough Humanized Model for Wilson's Disease Research
Unveiling New Frontiers in Vascular Disease Research: Novel Humanized Mouse Models for Angiogenesis
How APP Mutations Drive Aβ Accumulation in Alzheimer’s Disease
Choosing the Right Tumor Model for Preclinical Research
Share
Top
Ready to Elevate Your Research?
Discover how Cyagen can support your research. Let’s start a conversation.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research